Navigation Links
Engineered Viruses Could Battle Superbugs
Date:3/4/2009

Researchers say they disabled bacterial defenses, making antibiotics more effective

WEDNESDAY, March 4 (HealthDay News) -- American researchers say they've engineered a virus that disables the defense systems of bacteria to enhance the effectiveness of antibiotics.

The scientists said this approach could help prevent bacteria from becoming resistant to antibiotics and kill bacteria that have already become antibiotic resistant.

The Massachusetts Institute of Technology and Boston University scientists engineered existing bacteriophages (viruses that infect bacteria) to attack the SOS system -- a bacterial DNA repair system that bacteria use when they're exposed to antibiotics that damage DNA -- and other gene networks in bacteria.

The survival rate for mice infected with bacteria and treated with engineered bacteriophages and antibiotics was 80 percent, compared with 50 percent for mice treated with natural bacteriophages and antibiotics, 20 percent for mice treated with antibiotics alone, and 10 percent for untreated mice.

The study was published in the March 2 online issue of the journal Proceedings of the National Academy of Sciences.

"This work lays the groundwork for the development of a library of bacteriophages, each designed to attack different bacterial targets," lead author Timothy Lu, an M.D. candidate in the Harvard-MIT Division of Health Sciences and Technology, said in an MIT news release.

Antibiotic-resistant bacteria are a serious and growing health threat. For example, methicillin-resistant Staphylococcus aureus (MRSA) causes about 94,000 infections and contributes to 19,000 deaths each year in the United States, according to the U.S. Centers for Disease Control and Prevention.

New drugs are needed to combat such superbugs, but few new antibiotics have been developed in recent decades.

"There are a lot of targets to go after, but people haven't been able to find the drugs," Lu said.

More information

The U.S. Food and Drug Administration has more about antibiotic resistance.



-- Robert Preidt



SOURCE: Massachusetts Institute of Technology, news release, March 2, 2009


'/>"/>
Copyright©2009 ScoutNews,LLC.
All rights reserved  

Related medicine news :

1. Researchers design re-engineered hospital discharge program to reduce rehospitalization
2. Engineered virus targets and kills apparent cancer stem cells in neuroblastoma
3. FDA Issues Final Regulations for Genetically Engineered Animals
4. E. coli engineered to produce important class of antibiotic, anti-cancer drugs
5. Top Athletes Join Forces for a New Mission: Athlete-Engineered Skincare to Support Performance and Benefit Charity
6. FDA Proposes Regulations for Genetically Engineered Animals
7. Tumor suppressor genes speed up and slow down aging in engineered mouse
8. OrbusNeich Receives Approval to Market Genous(TM) Bio-engineered R stent(TM) in Taiwan
9. Symposium at Angioplasty Summit TCT Asia Pacific 2008 Features OrbusNeichs Genous(TM) Bio-engineered R stent(TM)
10. Reconstructing mandibular defects with bioengineered tooth and bone
11. Nanomedicine system engineered to enhance therapeutic effects of injectable drugs
Post Your Comments:
*Name:
*Comment:
*Email:
Related Image:
Engineered Viruses Could Battle Superbugs
(Date:3/29/2017)... ... ... Hamlin Dental Group, multi-location dental office in North Hollywood , Van ... safe and effective options, and can be used alone or in conjunction with other ... care. , Dr. Hamid Reza of Hamlin Dental Group offers other treatments as well, ...
(Date:3/29/2017)... ... , ... VisualSP has helped over 1.5 million SharePoint users learn the content ... of its Help System for SharePoint was at the farm level. Enterprises using SharePoint ... , The company recently released a modified version of the Help System, VisualSP ...
(Date:3/28/2017)... ... March 28, 2017 , ... ... team. Ruel Williamson brings his extensive knowledge of appraisals, property values, ad valorem ... the real estate valuation industry for more than 40 years. , “Ruel is ...
(Date:3/28/2017)... ... March 28, 2017 , ... City trips have soared 82% ... Trends Report). As travelers visit both urban destinations, they are faced with exploration ... exposure. In response, the outdoor industry has blurred the lines between fashion and ...
(Date:3/28/2017)... ... March 28, 2017 , ... ... the University of Pittsburgh Medical Center (UPMC) will acquire QuikClot® Bleeding Control Kits® ... The program, developed in association with efforts by the American College of Surgeons, ...
Breaking Medicine News(10 mins):
(Date:3/29/2017)... Neurim Pharmaceuticals ("Neurim") and Exeltis announced today ... for Neurim,s new Rx PedPRM in Spain . ... Neurim,s paediatric prolonged-release ... children with Autism Spectrum Disorders (ASD) and neurogenetic diseases. It is ... The collaboration with Exeltis will help increase the accessibility of ...
(Date:3/29/2017)... 29, 2017 Research and Markets has announced ... Software Market Outlook: 2016-2022" report to their offering. ... The global patient safety ... of delivery, end-user, and geography. Patient safety has ... globe. The field has developed significantly in the last decade and ...
(Date:3/28/2017)... 2017 The U.S. Food and Drug ... adults with moderate-to-severe eczema (atopic dermatitis). Dupixent is ... adequately by topical therapies, or those for whom ... used with or without topical corticosteroids. ... approving new and innovative therapies for patients with ...
Breaking Medicine Technology: